You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,602.9% | -305.7% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 130.8 | 25.9 |
| Price / Book value | 4.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 7.9% | -39.7% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 17.4% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | n/a | -3.87 | -8.12p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | 1.55 | -12.90 | -6.81p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-04-30 | 3.61 | -11.04 | -5.67p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2022-04-30 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Angle UK, US, Canada operations 'severely disrupted' by Covid-19 Sharecast News | 31 Mar |
|---|---|
| Angle upbeat on recent Parsortix research out of Italy Sharecast News | 27 Feb |
| Angle upbeat on German research into 'Parsortix' Sharecast News | 17 Feb |
| COVID-19 BUSINESS IMPACT UPDATE | 31-Mar-20 07:07 |
|---|---|
| Assessing risk of brain metastasis in lung cancer | 03-Mar-20 07:04 |
| Data demonstrates key advantages of Parsortix | 17-Feb-20 07:05 |
| Issue of Equity | 03-Feb-20 09:12 |
| Interim Results | 30-Jan-20 07:06 |